N/A
N=60
Hyperglycemia in Renal Transplantation
Diabetes · End Stage Renal Disease
Bottom Line
View on ClinicalTrials.gov: NCT01643382 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: Incidence of Poor Graft Function After Kidney Transplant — 13; 22 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Insulin (Drug); Insulin, Asp(B28)- (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, San Francisco
- Primary completion
- Aug 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Poor Graft Function After Kidney Transplant |
13; 22 | — |
Summary
Based on multiple prior studies, kidney transplant recipients with diabetes are at higher risk for poor initial graft function after transplant. Our study is designed to determine if tight blood sugar control around the time of kidney transplant will improve short term graft function.
Eligibility Criteria
Inclusion Criteria
- adult patients
- diabetic
- end stage renal disease undergoing cadaveric renal transplant
Exclusion Criteria
- enrolled in concurrent study to test impact of a drug on graft function after transplant
Data sourced from ClinicalTrials.gov (NCT01643382). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.